Splice it up: Atypical transcripts to boost leukemia immunotherapy.
Immunity
| Authors | |
| Abstract | Neoantigens are prime targets for cancer immunotherapy, but their identification in low mutational burden malignancies remains challenging. In this issue of Immunity, Ehx et al. show that atypical transcripts, and particularly retained introns, expand the spectrum of leukemia immunotherapy targets. |
| Year of Publication | 2021
|
| Journal | Immunity
|
| Volume | 54
|
| Issue | 4
|
| Pages | 608-610
|
| Date Published | 2021 Apr 13
|
| ISSN | 1097-4180
|
| DOI | 10.1016/j.immuni.2021.03.016
|
| PubMed ID | 33852826
|
| Links |
